Common use of Study Design Clause in Contracts

Study Design. The study is a multicentre, two-arm, randomised, double-blind clinical trial, using temozolomide as an active comparator. Following completion of radiotherapy treatment according to the ‘▇▇▇▇▇ regimen’, subjects will be assigned to one of two treatment groups, in a 1:1 ratio. The first group will receive temozolomide, in accordance with the labelled dose and schedule. The second group will receive GDC-0084 at a dose of 45mg, once daily.